Follow the 신테카바이오 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 신테카바이오 has recorded 84 reports. Market capitalisation: €29.4bn. The latest transaction was filed on 15 July 2026 (Purchase). Among the most active insiders: 정종선. The full history is openly available.
82
Insider Decl.
n/a
Thresholds
n/a
43 ops.
Buy Volume
n/a
9 ops.
Sell Volume
Fundamental score
Ranked 24,075 of 29,068 companies
28.6
score / 100
Value
5
Quality
52
FCF yld-36%
Earn yld-59%
EV/EBITDA·
ROE-59%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
신테카바이오 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for the medical field.